Most patients with diffuse large B‐cell lymphoma (DLBCL) are diagnosed at age 60 years or
older. Challenges to effective therapy among older individuals include unfavorable biologic …

Opinion statement Patients with hematologic malignancies and their families are among the
most distressed of all those with cancer. Despite high palliative care-related needs, the …

Background Despite favorable prognoses, pediatric patients with hematologic malignancies
experience significant challenges that may lead to diminished quality of life or family stress …

Abstract Purpose of Review The medical field has a critical role not only in prolonging life
but also in helping patients achieve a good death. Early studies assessing end-of-life quality …

Background: Patients with hematologic malignancies (HMs) receive more disease directed
care at the end of life (EOL) and often die in the hospital. The impact of early palliative care …

Context The outcomes of specialty palliative care (PC) interventions for patients with
hematologic malignancies (HMs) is under-investigated. Objectives We performed a …

Objetivo: identificar las tendencias de investigación sobre el cáncer de pulmón durante los
últimos cinco años, desde la perspectiva del cuidado de enfermería. Método: revisión …

Hematologic malignancies are heterogeneous and have unpredictable illness trajectories.
Intensive therapies, such as hematopoietic stem cell transplant (HSCT) and chimeric antigen …

Background Palliative care (PC) contributes to improved end-of-life care for patients with
hematologic malignancies (HM) and solid tumors (ST) by addressing physical and …

Purpose The existing concept suggests early palliative and hospice therapy for a better
quality of care (QOC) and less medical expense in terminal cancer patients, but the time …